Invention Grant
- Patent Title: Substituted imidazoles as N-type calcium channel blockers
-
Application No.: US15892846Application Date: 2018-02-09
-
Publication No.: US10653673B2Publication Date: 2020-05-19
- Inventor: Ishtiyaque Ahmad , Rajagopal Bakthavatchalam , Sivaramakrishna Battula , Henricus Jacobus Maria Gijsen , Saravanan Vadivelu , Mark Wall , Christopher Flores
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Agency: Insigne LLP
- Main IPC: A61K31/4178
- IPC: A61K31/4178 ; C07D405/14 ; C07D405/04 ; A61K31/4196 ; A61K31/4439 ; A61K31/444 ; A61K31/497 ; A61K31/506
Abstract:
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, and G are defined herein.
Public/Granted literature
- US20180161312A1 SUBSTITUTED IMIDAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS Public/Granted day:2018-06-14
Information query
IPC分类:
